Literature DB >> 7354108

Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis.

J S Sawers, A D Toft, W J Irvine, N S Brown, J Seth.   

Abstract

Thirty consecutive patients with thyrotoxicosis were followed up at monthly intervals for 6 months after treatment with iodine-131. Serum total T4, serum total T3, and serum TSH response to TRH were measured at each review. Biochemical evidence of hypothyroidism (low T4 raised basal TSH) developed in 18 patients 1-4 months after treatment. In 5 of these patients, symptoms and signs of hypothyroidism remained absent or minimal and spontaneous recovery of thyroid function occurred during the ensuing 2 months. If biochemical hypothyroidism occurs during the first 6 months after radioiodine therapy, it is recommended that T4 replacement be withheld for 2 months unless the severity of symptoms demands treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354108     DOI: 10.1210/jcem-50-2-226

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Thyroxine prescription.

Authors:  A Jones
Journal:  Br J Gen Pract       Date:  1993-10       Impact factor: 5.386

2.  The early follow-up of 131I-treatment of thyrotoxicosis.

Authors:  D M Solheim; L N Daae
Journal:  Eur J Nucl Med       Date:  1983

3.  A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.

Authors:  C Marcocci; D Gianchecchi; I Masini; F Golia; C Ceccarelli; E Bracci; G F Fenzi; A Pinchera
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

4.  Outcome of treatment of hyperthyroidism.

Authors:  I M Bringmann; B L van Leeuwen; G Hennemann; G J Beckett; A D Toft
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

5.  Late and transient increases in free T4 after radioiodine treatment for Graves' disease.

Authors:  A D Stensvold; R Jorde; J Sundsfjord
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

Review 6.  Subclinical hypothyroidism. To treat or not to treat.

Authors:  E A Laryea
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

7.  Low-dose 131I in treatment of Graves' disease.

Authors:  C P Lowdell; H J Dobbs; G S Spathis; V R McCready; D O Cosgrove; C L Harmer
Journal:  J R Soc Med       Date:  1985-03       Impact factor: 5.344

8.  The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.

Authors:  N R Peden; I R Hart
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

9.  Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis.

Authors:  F W Gibb; N N Zammitt; G J Beckett; M W J Strachan
Journal:  J Endocrinol Invest       Date:  2013-04-30       Impact factor: 4.256

10.  Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.

Authors:  Anthony Lewis; Brew Atkinson; Patrick Bell; Hamish Courtney; David McCance; Karen Mullan; Stephen Hunter
Journal:  Ulster Med J       Date:  2013-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.